SCHEMBL249764

SCHEMBL249764

CCCCOCCC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.54
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
TSHR P16473 5/20 0.52
HDAC11 Q96DB2 5/20 0.52
PTPN1 P18031 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
KMT2A Q03164 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52
ALOX15 P16050 1/20 0.52
PDE4A P27815 1/20 0.52
PDE3A Q14432 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476951 0.98 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL2948128 0.98 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL11764726 0.98 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL2947287 0.98 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL3799105 0.93 AKR1B1 (0.58) AKR1B1GPR84PPARGPPARDPPARA
Succinic Acid SCHEMBL12980700 0.93 AKR1B1 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL23199861 0.91 GPR84 (0.60) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL22492286 0.91 GPR84 (0.60) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL21357737 0.91 GPR84 (0.60) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL21753105 0.91 GPR84 (0.60) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 626 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118742541-A Ultraviolet light absorber 巴斯夫欧洲公司 2024-10-01 CN claimed
CN-117599684-A Device and method for producing acrylic acid and ester by cracking acrylic acid and ester heavy component 平湖石化有限责任公司 2024-02-27 CN claimed
CN-114318859-B Reinforced silicon crystal net and preparation method thereof 山东大庚工程材料科技有限公司 2023-10-27 CN claimed
CN-114318859-A Reinforced silicon crystal net and preparation method thereof 山东大庚工程材料科技有限公司 2022-04-12 CN claimed
WO-2020139007-A1 METALLIC PAINT COMPOSITION AND METHOD FOR MANUFACTURING POLYMER INJECTION MATERIAL FORMED WITH METAL FILM USING SAME (주)잉크테크 2020-07-02 WO claimed
CN-106905155-B Method for generating butyl acrylate by cracking butyl acrylate heavy component 万华化学集团股份有限公司 2020-04-10 CN claimed
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2019-08-27 US claimed
US-9649713-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2017-05-16 US claimed
US-20170064823-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2017-03-02 US claimed
US-9532493-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2016-12-27 US claimed
CN-1935236-B Quality control method for Chinese medicine injection preparation BEIJING QIYUAN YIDE INST OF MATERIA MEDICA 2010-04-21 CN claimed
CN-101158670-A Quality control method of pharmaceutical composition BEIJING QI YUAN YI PHARM RES (CN) 2008-04-09 CN claimed
US-20070238669-A1 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS BRISTOL-MYERS SQUIBB COMPANY 2007-10-11 US claimed
EP-1497405-B1 COMPOSITION COMPRISING A MIXTURE OF ALKYL MONO AND POLYLACTYLLACTATE ARKEMA FRANCE (FR) 2006-10-04 EP claimed
EP-1497405-A1 COMPOSITION COMPRISING A MIXTURE OF ALKYL MONO AND POLYLACTYLLACTATE ARKEMA (FR) 2005-01-19 EP claimed
WO-2003087284-A1 COMPOSITION COMPRISING A MIXTURE OF ALKYL MONO AND POLYLACTYLLACTATE ATOFINA (FR) 2003-10-23 WO claimed
US-20020076651-A1 FAST DRYING THICK FILM NEGATIVE PHOTORESIST MICROCHEM CORP., A CORPORATION OF THE STATE OF MASSACHUSSETS 2002-06-20 US claimed
US-6391523-B1 EPOXIDIZED POLYFUNCTIONAL BISPHENOL A-FORMALDEHYDE NOVOLAK RESIN AND PHOTOACID GENERATOR IN COATING SOLVENT OF CYCLOPENTANONE MICROCHEM CORP. 2002-05-21 US claimed
WO-1997031982-A1 THE USE OF ALKYL 3-ALKOXYPROPIONATES AS COALESCING AGENTS IN AQUEOUS COATING COMPOSITIONS EASTMAN CHEMICAL COMPANY (US) 1997-09-04 WO claimed
EP-0261775-B1 BINDER COMPOSITIONS CONTAINING PHENOLIC RESINS AND ESTERS OF ALKOXY ACIDS ACME RESIN CORPORATION (US) 1992-06-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238669-A1 HUMAN GLUCAGON-LIKE-PEPTIDE-1 MODULATORS AND THEIR USE IN THE TREATMENT OF DIABETES RELATED CONDITIONS GLP1R, GIPR, IAPP AKR1B1 1280/4885GPR84 113/4885PPARG 250/4885
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SOD1, SOD3, AOC3 AKR1B1 3339/4885GPR84 4273/4885PPARG 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.